Tata Capital raises second life-sciences & healthcare PE fund of Rs 955 Cr

28 March 2022 | News

To invest across sub-sectors of pharmaceuticals, healthcare delivery, medical devices and digital health

Image credit: Shutterstock

Image credit: Shutterstock

Tata Capital Healthcare Fund II (TCHF II), sponsored by Tata Capital, has announced the Final Close of its fund with investor commitments of Rs 955 crores (~$126 million), meeting its target AUM of Rs 950 crores (excluding green-shoe). This was a follow-up to the Tata Capital Healthcare Fund I which had raised Rs 411 crore (~$70 million) in 2012.


Visalakshi Chandramouli, Managing Partner, TCHF said, “TCHF II will seek to achieve returns by principally taking equity positions in healthcare and life sciences-related companies having significant business exposure to India."


The investment strategy of TCHF II is predicated on the following two themes-


Domestic Healthcare and Life Sciences Consumption: Focussed on the Indian consumption story in healthcare and life sciences-related businesses. It is estimated that 60 per cent of TCHF II’s investments will cater to this theme.


Healthcare and Life Sciences Competency: Focussed on leveraging India’s expertise in the healthcare and life sciences sectors to deliver products/services to the world markets. It is estimated that 40 per cent of TCHF II’s investments will cater to this theme. 


Vamesh Chovatia, Partner of TCHF said, “The fund will typically look at committing $5mn - $15 million per transaction and potentially a larger ticket size along with co-investment support from its Limited Partners who have committed to invest in the fund.”



× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account